Noaxa: The Only Product Containing AHCC® Professional in Iran
AHCC® Professional is an innovative and highly effective solution designed to help clear HPV from the body. Amino Up Co.,...
News & Events
Cobel Darou Launches Velorita® for the Comprehensive Management of Diabetes and Obesity A Novel Treatment in Weight Management, Blood Glucose Control, and Cardiovascular, Renal, and Hepatic Protection
Cobel Darou has introduced Canadian-manufactured Semaglutide to the Iranian pharmaceutical market under the brand name Velorita®. The launch of this...
Damonzia®: Cobel Darou’s Novel Oral Treatment for Chronic Autoimmune Diseases
With the introduction of Damonzia®, Cobel Darou has taken a significant step forward in advancing oral therapies for chronic autoimmune...
Ziveria®: Dr. Abidi Pharmaceuticals’ Novel Solution for the Treatment of Allergic Diseases
Dr. Abidi Pharmaceuticals has manufactured and launched Bilastine under the brand name Ziveria® to control the symptoms of allergic rhinitis...
Dr. Abidi Pharmaceuticals Takes a New Step in Targeted Migraine Treatment with the Launch of the Novel Drug Repiva®
Dr. Abidi Pharmaceuticals has unveiled Repiva® as a novel and effective solution for the acute treatment of migraine attacks, offering...
Noaxa Capsules Available in Pharmacies in Both Clear and Bicolor Shells
The Noaxa supplement, manufactured by Dr. Abidi Pharmaceuticals, is the only Iranian product containing AHCC® Pro from Amino Up Co.,...
Continuing to Drive the Paradigm Shift in the Treatment of Cardiometabolic Diseases; Dr. Abidi Pharmaceuticals Enters the Obesity Treatment Arena with the Introduction of Zcorpa®
Dr. Abidi Pharmaceuticals has launched the highly effective and innovative drug Tirzepatide under the brand name Zcorpa®. Zcorpa® is an...
Miqlon®; Dr. Abidi Pharmaceuticals’ Novel Solution for the Treatment of Kidney and Heart Failure
For the first time, Dr. Abidi Pharmaceuticals has introduced the innovative drug Finerenone, under the brand name Miqlon®, to the...
Dr. Abidi Pharmaceuticals’ Medical Team Visits Ilam to Enhance Treatment Accessibility for Epilepsy Patients
In October 2025, on the eve of Dr. Abidi Pharmaceuticals' 80th anniversary, a team of neurologists, accompanied by colleagues from...
The 4th “Abidi Scientific Awards” to be Held with the Addition of Gastroenterology, Hepatology, and Neurology Therapeutic Areas
Based on the decision of the Scientific Committee of the Abidi Scientific Awards, research works and articles in the fields...
Phorize®: Revolutionizing Heartburn Management with Rapid and Sustained Efficacy
Dr. Abidi Pharmaceuticals' Latest Milestone in Controlling Acid Reflux and Gastrointestinal Diseases Dr. Abidi Pharmaceuticals has proudly manufactured and launched...
30 Years of Continuous Experience and Innovation Dr. Abidi Pharmaceuticals’ Leading Role in Advancing Gastrointestinal Therapeutics
Exactly 30 years ago, the global medical landscape was revolutionized by the introduction of the first Proton Pump Inhibitor (PPI),...
